Global leader in cellular imaging unveils latest imaging and analysis
software platform with new measurement capabilities for better
understanding of intercellular and intracellular relationships
WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc., a global leader focused on improving the health and safety of
people and the environment, today announced the release of Volocity®
6.0, the latest version of the Company's 3D cellular imaging
software.
The Volocity software features a suite of high performance tools for
exploring, interacting and publishing 3D imaging data from cells,
tissues and organisms and how they behave over time - for greater
insights and knowledge into cellular interactions. The software is
designed as a universal solution that provides users with significant
functionality to visualize, analyze and validate 3D fluorescence images
from a wide range of confocal microscopy, wide-field and high content
screening systems, and is fully integrated for a seamless user
experience.
"PerkinElmer is committed to supporting new discoveries that will
ultimately lead to new treatments in disease research fields such as
cancer and neurodegeneration," said Achim von Leoprechting, vice
president, Imaging and Detection Solutions, Bio-discovery, PerkinElmer.
"Through new applications and enhanced imaging capabilities, the new
Volocity 6.0 software will help scientists better understand how
diseases affect cells as well as how potential therapies affect diseased
and healthy cells."
Beyond simple cells, the Volocity software can also organize and relate
measurements according to biological classification such as nuclei,
membranes, organelles, and proteins, making it easier and faster to
perform an analysis and understand the results. The updated interface
also enables users of all skill levels to perform complex and
challenging biological measurements, thereby extending the power of 3D
analysis to a wider population of potential users.
Key new features of the Volocity 6.0 suite enable end-users to:
-
Benefit from more interactivity and even simpler workflows to obtain
quantitative 3D answers more quickly and easily.
-
Define and measure cells, organelles, or other biological structures,
and the relationships between them, with greater ease.
-
Measure distances in 3D between structures across a whole field or
within biologically relevant compartments such as cells or nuclei.
-
Perform FRAP analysis on data that has not been acquired in Volocity
software.
-
Faster and easier export of multiple, processed images for
presentation and for use in other applications.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $1.7 billion in 2010, has about 6,200 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Edelman (on behalf of PerkinElmer, Inc.)
Amanda L. Connolly
Direct:
404-832-6785
amanda.connolly@edelman.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media